How to Operationalize Your DCT or Hybrid Trial: Best Practices for Emerging Biopharma

DCT/hybrid clinical trials are becoming the industry norm, but what can Emerging Biopharma learn from the experience of Big Pharma? Watch this webinar for best practice advice and key tips from experts on how to operationalize your hybrid and DCT trials.

Register Free: https://www.appliedclinicaltrialsonline.com/act_w/emerging-biopharma

Event Overview:

There is a lot of buzz in the industry about the importance and value of both decentralized clinical trials (DCTs) and hybrid clinical trials, but what is being done to actually operationalize them, particularly in smaller and midsize biotech organizations? How can Emerging Biopharma implement hybrid and DCT strategies that keep up with dynamic regulatory guidance and industry standards. While elements of DCTs have been part of clinical trials for quite some time, the boundaries continue to expand, moving beyond remote technology and into home healthcare, direct-to-patient shipments, and more. Even as these elements help to increase opportunities for patient participation, they raise numerous challenges in many areas, including design, conduct, and data quality.

In this free webcast, sponsors can learn best practices for operationalizing their hybrid and DCT clinical trials with practical advice from two of Advanced Clinical’s senior leaders. The Advanced Clinical team welcomes your questions both during and after the webcast Q&A, as it will help round out the discussion and make it more relevant to your unique challenges.

Key Learning Objectives:

• Increase your understanding of the changing regulatory and technology guidance for DCTs and hybrid trials, and learn what this means for sponsors.
• Hear insight into best practices for Emerging Biopharma looking for ways to operationalize their DCTs and hybrid trials.
• Learn about shifts in roles in DCTs and how sponsors can plan for the future workforce.
• Examine the impact of DCTs on enrollment diversity and inclusion initiatives and learn what this means to sponsors.
• Learn how to overcome the challenges in operationalizing DCT and hybrid clinical trials with practical advice from teams in the field

Who Should Attend:

• Small to mid-size Biotechs – job functions of VP, Director or Manager in the areas of Clinical Operations, Clinical Trial Management Program/Project Management, Site Management

Speakers:

Caroline Redeker
Senior Vice President, Corporate Development
Advanced Clinical

Caroline Redeker is a results-oriented and accomplished professional with more than 25 years of clinical research experience, and she’s responsible for driving global expansion, creating new service offerings and building corporate efficiencies for Advanced Clinical. Prior to joining Advanced Clinical, Caroline worked within multiple contract research organizations, a site management organization and one of the first professional independent research sites. She previously served in a corporate development role, primarily focused on the acquisitions and merger integrations of three companies. Caroline has also served in roles such as corporate officer, board secretary and multiple-level roles within patient recruitment, site budget/contract negotiations, business development and marketing. In the past decade, she has led and grown multiple business development and marketing teams and managed key strategic client relationships. Caroline is driven by the perspective of the client and is passionate about delivering exceptional service and a better overall experience for Advanced Clinical’s clients.

Cheryle Evans
Senior Vice President, Global Clinical & Biometric Operations
Advanced Clinical

Cheryle Evans is a senior-level executive with extensive, progressive clinical research experience and is responsible for the strategic planning and tactile operations in project management, clinical monitoring, site activation, safety and document management. She has led global teams across multiple disciplines, successfully utilizing automation to improve quality and streamline operations. Prior to joining Advanced Clinical in 2013, Cheryle was the VP of Clinical Monitoring, NA, with inVentiv Health Clinical, where she led the optimization of three global strategic units: Global Study Start-Up, Expedited Safety Reporting and Document Management and Publishing. Prior to her tenure with inVentiv Health Clinical, Cheryle was part of a strategic team for which she supported the transition and growth from a site management organization to a top-five, global, full-service CRO. Cheryle has therapeutic expertise in cardiovascular, urologic, dermatologic and women’s/men’s health clinical trials.

Register Free: https://www.appliedclinicaltrialsonline.com/act_w/emerging-biopharma